KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 122 filers reported holding KURA ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $325,000 | -15.8% | 20,196 | -26.7% | 0.02% | -26.1% |
| Q4 2021 | $386,000 | +46.2% | 27,537 | +117.4% | 0.02% | +64.3% |
| Q2 2021 | $264,000 | -46.0% | 12,666 | -26.8% | 0.01% | -50.0% |
| Q1 2021 | $489,000 | -42.1% | 17,305 | -33.0% | 0.03% | -54.1% |
| Q4 2020 | $844,000 | -56.2% | 25,827 | -58.9% | 0.06% | -3.2% |
| Q3 2020 | $1,927,000 | +94.1% | 62,901 | +3.3% | 0.06% | +142.3% |
| Q2 2020 | $993,000 | +111.7% | 60,899 | +29.1% | 0.03% | +116.7% |
| Q1 2020 | $469,000 | -37.6% | 47,155 | -13.8% | 0.01% | +9.1% |
| Q4 2019 | $752,000 | +234.2% | 54,724 | +303.0% | 0.01% | +120.0% |
| Q1 2019 | $225,000 | +16.0% | 13,579 | -2.0% | 0.01% | +25.0% |
| Q4 2018 | $194,000 | -40.3% | 13,851 | -25.5% | 0.00% | -42.9% |
| Q3 2018 | $325,000 | – | 18,592 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |